Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.12
+0.14 (1.45%)
At close: Jun 23, 2026, 4:00 PM EDT
10.00
-0.12 (-1.14%)
After-hours: Jun 23, 2026, 5:54 PM EDT
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $2.21 billion as of June 23, 2026. Its market cap has increased by 54.14% in one year.
Market Cap
2.21B
Enterprise Value
1.63B
1-Year Change
54.14%
Ranking
Category
Stock Price
$10.12
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $2.21B, an increase of 718.77%. That is a compound annual growth rate of 19.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 2.21B | -14.37% |
| Dec 31, 2025 | 2.59B | 92.64% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
| Jul 25, 2014 | 270.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intellia Therapeutics | 2.19B |
| Immunome | 2.12B |
| Aurinia Pharmaceuticals | 2.12B |
| Nektar Therapeutics | 2.06B |
| MBX Biosciences | 2.05B |
| Vericel | 2.05B |
| Biohaven | 2.04B |
| Zai Lab | 2.04B |